Skip to main content
Loading

Advancing Oligonucleotide Therapeutics: From Molecule Design to Precision Delivery

02 Dec 2025
Translational & Clinical Strategy
Industry Expert
Ranganath Gopalakrishnan, Director, New Modalities, Medicinal Chemistry, Early CVRM - AstraZeneca